Found 19 matching trials
JSKN003 Combined Treatment of HER2-positive Gastric Cancer
PHASE2This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Location
Multiple Locations
Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer
PHASE2This is a prospective, single-center, single-arm study evaluating the combi...
Location
Tianjin Medical University Cancer Institute & Hospital
A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
PHASE2This study is designed to compare the efficacy and safety of KN026 combined...
Location
Multiple Locations
A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
PHASE2This is a prospective , single - arm clinical study , aiming to evaluate th...
Location
Multiple Locations
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
PHASE2This is an open-label, multicenter Phase II clinical study conducted in sub...
Location
Multiple Locations
Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC
PHASE2Efficacy and safety of short-course radiotherapy in total neoadjuvant thera...
Location
Hebei Medical University Fourth Hospital
Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer
PHASE1This trial is an open-label, dose-escalation, and randomized controlled Pha...
Location
Multiple Locations
Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer
PHASE2This is a prospective, single-center, single-arm exploratory clinical study...
Location
Multiple Locations
SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
PHASE2This study is a n open-label, multi-center, phase II study to evaluate the ...
Location
Shanghai East Hospital Affiliated To Tongji University
SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer
PHASE2Efficacy and Safety of SYHX2011 Combined with Carboplatin and Enlonstobart ...
Location
Multiple Locations